$MOLN
MOLECULAR PARTNERS AG
CIK:0001745114|SEC Filings
Consolidated Statement of Financial Position - CHF (SFr) SFr in Thousands |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Assets | ||
| Property, plant and equipment | SFr 5,229 | SFr 4,198 |
| Intangible assets | 2 | 49 |
| Total non-current assets | 5,231 | 4,247 |
| Short-term time deposits | 10,405 | 85,565 |
| Other current assets | 1,985 | 2,525 |
| Trade and other receivables | 1,834 | 2,317 |
| Cash and cash equivalents | 82,653 | 63,874 |
| Total current assets | 96,876 | 154,281 |
| Total assets | 102,107 | 158,528 |
| Shareholders' equity and liabilities | ||
| Share capital | 4,037 | 4,036 |
| Additional paid-in capital | 389,179 | 384,875 |
| Treasury share reserve | (1,129) | (981) |
| Cumulative losses | (311,753) | (246,293) |
| Total shareholders' equity | 80,334 | 141,637 |
| Trade and other payables | 160 | 0 |
| Lease liability | 2,438 | 1,227 |
| Employee benefits | 8,147 | 4,879 |
| Total non-current liabilities | 10,746 | 6,106 |
| Trade and other payables | 1,767 | 1,859 |
| Accrued expenses | 8,055 | 7,709 |
| Lease liability | 1,206 | 1,217 |
| Total current liabilities | 11,027 | 10,785 |
| Total liabilities | 21,772 | 16,891 |
| Total shareholders' equity and liabilities | SFr 102,107 | SFr 158,528 |